Tobacco industry manipulation of research

Public Health Reports

Volumn 120, Issue 2, 2005, Pages 200-208

  Bero, Lisa A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Box 0613 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE; NICOTINE; PETROLEUM; PLASTIC; TOBACCO SMOKE; TOXIN;

AIR QUALITY; AMBIENT AIR; ENVIRONMENTAL PROTECTION; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; LAW; PASSIVE SMOKING; PEER REVIEW; POLICY; PRIORITY JOURNAL; PUBLICATION; RESEARCH; REVIEW; RISK ASSESSMENT; TOBACCO INDUSTRY;

EID: 16844384447     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: 10.1177/003335490512000215     Document Type: Review

References (86)

1. Krimsky S. The role of theory in risk studies. In: Krimsky S, Golding D, editor's. Social theories of risk. Westport (CT): London; 1992. p. 3-22.
2. Nelkin D. The language of risk: conflicting perspectives on occupational health. Beverly Hills: Sage Publications; 1985. p. 200.
3. Lowi T. The end of liberalism. New York: Norton; 1979.
4. Walker JL. Mobilizing interest groups in America. Ann Arbor: University of Michigan Press; 1991.
5. Truman D. The governmental process. Berkeley: Institute of Governmental Studies Press; 1993.
6. Jasanoff SK. Is science socially constructed and can it still inform public policy? Sci Eng Ethics 1996;2:263-76.
7. Wallack L, Dorfman L, Jernigan D, Themba M. Media advocacy and public health: power for prevention. Newbury Park (CA): Sage Publications; 1993.
8. Jasanoff S. The technical discourse of government. Cambridge (MA): Harvard University Press; 1995. p. 69-92.
9. Kingdon JW. Agendas, alternatives, and public policies. Boston: Little, Brown and Co.; 1984.
10. Mazmanian D, Sabatier K Implementation and public policy. Lanham (MD): University Press of America; 1989.
11. Sabatier PA. Toward better theories of the policy process. Political Sci Process 1991;!47-56.
12. Stayner L. Protecting public health in the face of uncertain risks: the example of diesel exhaust. Am J Public Health 1999;89:991-3.
13. Ong EK, Glantz SA. Constructing "Sound Science" and "Good Epidemiology": tobacco, lawyers, and public relations firms. Tob Control 2001;91:1-9.
14. Hirschhorn N, Bialous S. Second-hand smoke and risk assessment: what was in it for the tobacco industry? Tob Control 2001;10:375-82.
15. Bialous S, Yach D. Whose standard is it, anyway? how the tobacco industry determines the International Organization for Standardization (ISO) standards for tobacco products. Tob Control 2001;10:96-104.
16. Bero L. Implications of the tobacco industry documents for public health and policy. Annu Rev Public Health 2003;24:267-88.
17. Glantz S, Slade J, Bero L, Hanauer P. The cigarette papers. Berkeley: University of California Press; 1996.
18. Roper Organization. A study of public attitudes towards cigarette smoking and the tobacco industry in 1978. Vol. 1. Roper Organization; 1978.
19. Barnoya J, Glantz S. The tobacco industry's worldwide ETS consultants project: European and Asian components. Eur J Public Health. In press.
20. Chapman S. Tobacco industry memo reveals passive smoking strategy. BMJ 1997;314:1569.
21. Muggli ME, Forster JL, Hurt RD, Repace JL. The smoke you don't see: uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies. Am J Public Health 2001;91:1419-23.
22. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
23. Barnes D, Bero L. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998;279:1566-70.
24. Barnes DE, Bero IA. Scientific quality of original research articles on environmental tobacco smoke. Tob Control 1997;6:19-26.
25. Malone RE, Bero LA. Chasing the dollar: why scientists should decline tobacco industry funding. J Epidemiol Community Health 2003;57:546-8.
26. Bero L, Barnes D, Hanauer P, Slade J, Glantz S. Lawyer control of the tobacco industry's external research program: the Brown and Williamson documents. JAMA 1995;274:241-7.
27. Hammer P, Slade J, Barnes D, Bero L, Glantz. S. Lawyer control of internal scientific research to protect against products liability lawsuits: the Brown and Williamson documents. JAMA 1995;274:234-40.
28. Barnes D, Bero L. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Politics Policy Law 1996;21:515-42.
29. Center for Indoor Air Research. Request for applications: 1989-1990 research agenda. Center for Indoor Air Research; 1989.
30. Center for Indoor Air Research. Center for Indoor Air Research 1992 research agenda and request for applications. Center for Indoor Air Research; 1992.
31. Tobacco Institute. Tobacco smoke and the non-smoker: scientific integrity at the crossroads. Tobacco Institute; 1986.
32. Turner S, Cyr S, Gross A. The measurement of environmental tobacco smoke in 585 office environments. Environ Int 1992;18:19-28.
33. Hirschhorn N, Bialous SA, Shatenstein S. Philip Morris' new scientific initiative: an analysis. Tob Control 2001;10:247-52.
34. Bero LA, Galbraith A, Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA 1994;271:612-7.
35. Barnoya J, Glantz. S. Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the "Latin Project." Tob Control 2002;11:305-14.
36. National Research Council. Environmental tobacco smoke: measuring exposures and assessing health effects. Washington: National Academy Press: 1986.
37. Department of Health and Human Services (US). The health consequences of involuntary smoking: a report of the Surgeon General. Washington: DHHS; 1986.
38. Schotland MS, Bero LA. Evaluating public commentary and scientific evidence submitted in the development of a risk assessment. Risk Anal 2002;22:131-40.
39. Chapman S, Borland R, Hill D, Owen N, Woodward S. Why the tobacco industry fears the passive smoking issue, Int J Health Serv 1990;20:417-27.
40. Bero LA, Glantz. SA. Tobacco industry response to a risk assessment of environmental tobacco smoke. Tob Control 1993;2:103-13.
41. RJR Reynolds Tobacco Company. Passive smoking: an active controversy [advertisement], circa 1993.
42. Rochon P. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journals. JAMA 1994;272:108-13.
43. Clio MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Int Med 1996;124:485-9.
44. Montini T, Bero LA. Policy makers' perspectives on tobacco control advocates' roles in regulation development. Tob Control 2001;10:218-24.
45. Montini T, Mangurian C, Bero LA. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland. Public Health Rep 2002;117:291-8.
46. Dickersin K, Min Y-I, Meinen CL. Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA 1992;267:374-8.
47. Armitage AK. Environmental tobacco smoke and coronary heart disease. J Smoking-Relat Dis 1993;4:27-36.
48. Bero LA, Glantz SA, Rennie D. Publication bias and and public health policy on environmental tobacco smoke. JAMA 1994;272:133-6.
49. Misakian S, Bero L. Publication bias and research on passive smoking. JAMA 1998;280:250-3.
50. Bero L, Rennie D. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA 1995;274:1935-8.
51. Hong MK, Bero LA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ 2002;325:1413-6.
52. Slade J, Bero L, Hanauer P, Barnes D, Glantz S. Nicotine and addiction: the Brown and Williamson documents. JAMA 1995;274:225-33.
53. Barnes D, Hanauer P, Slade J, Bero L, Glantz, S. Environmental tobacco smoke: the Brown and Williamson documents. JAMA 1995:274:248-53.
54. Rennie D. Smoke and letters [editorial]. JAMA 1993;270:1742-3.
55. Raymond CA. Risk in the press: conflicting journalistic ideologies. In: Nelkin D. The language of risk. Beverly Hills (CA): Sage Publications: 1985. p. 87-132.
56. Kennedy G, Bero L. Print media coverage of research on passive smoking. Tob Control 1999;8:254-60.
57. Malone R, Boyd E, Bero L. Science in the news: journalists' constructions of passive smoking as a social problem. Soc Stud Sci 2001;30:713-35.
58. Roth AL, Dunsby J, Bero LA. Framing processes in public commentary on US federal tobacco control regulation. Soc Stud Sci 2003;33:7-44.
59. Bero LA, Montini T, Bryan-Jones K, Mangurian C. Science in regulatory policy making: case studies in the development of workplace smoking restrictions. Tob Control 2001;10:329-36.
60. Bryan-Jones K, Bero L. Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality rule. Am J Public Health 2003;93:585-92.
61. Jasanoff S. EPA's regulation of daminozicle: unscrambling the messages of risk. Sci Technol Hum Values 1987;12:116-24.
62. Silbergeld E. Risk assessment: the perspective and experience of U.S. environmentalists. Environ Health Perspect 1993;101:100-4.
63. Wilson JQ. Bureaucracy: what government agencies do and why they do it. Baltimore: Johns Hopkins University Press; 1989.
64. Environmental Protection Agency (US). Respiratory health effects of passive smoking: lung cancer and other disorders. Washington: EPA, Office of Research and Development, Office of Health and Environmental Assessment; 1992.
65. California Environmental Protection Agency. Health effects of exposure to environmental tobacco smoke. Sacramento: California Environmental Protection Agency; 1997.
66. Mangurian C, Bero L. Lessons learned from the tobacco industry's efforts to prevent the passage of a workplace smoking regulation. Am J Public Health 2000;90:1926-30.
67. Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. BMJ 1981;282:183-5.
68. Lee PN. "Marriage to a smoker" may not be a valid marker of exposure in studies relating environmental tobacco smoke to risk of lung cancer in Japanese non-smoking women. Int Arch Occup Environ Health 1995;67:287-94.
69. Bekelman J, Li Y Gross C. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289:454-65.
70. Bero LA, Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care 1996;12:209-37.
71. Nestle M. Food politics: how the food industry influences nutrition and health. Berkeley: University of California Press; 2002.
72. Levine J, Gussow J, Hastings D, Eccher A. Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am J Public Health 2003;93:664-9.
73. Markowitz, G, Rosner D. Deadly dust: silicosis and the politics of occupational disease in twentieth century America. Princeton (NJ): Princeton University Press; 1991.
74. Markowitz G, Rosner D. "Cater to the children": the role of the lead industry in a public health tragedy, 1900-1955. Am J Public Health 2000;90:36-46.
75. Markowitz, G, Rosner D. Deceit and denial: the deadly politics of industrial pollution. Berkeley: University of California Press; 2002.
76. Boyd E, Bero L. Assessing faculty financial relationships with industry. JAMA 2000;284:2209-38.
77. von Winterfeldt D. Expert knowledge and public values in risk management: the role of decision analysis. In: Krimsky S, Golding D, editors. Social theories of risk. Westport (CT): London; 1992. p. 321-42.
78. Cho M. Fundamental conflict of interest. BioMedNet Magazine 1998;24.
79. Krimsky S. Science in the private interest. Lanham (MD): Rowman & Littlefield Publishers, Inc.; 2003.
80. Dana J. Harm avoidance and financial conflict of interest. Pittsburgh: Carnegie Bosch Institute; 2003. p. 1-18.
81. Schafer A. Biomedical conflicts of interest: a defence of the sequestration thesis. J Med Ethics 2003:1-40 [cited 2004 NOV]. Available from: URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd =Retrieve&db= PubMed&dopt=Citation&list_uids= 14872066
82. Shamoo AE, Resnik DB. Responsible conduct of research. New York: Oxford University Press; 2003.
83. Boyd EA, Cho MK, Bero LA. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med 2003;78:769-74.
84. Herman R. Harvard School of Public Health faculty votes not to accept funds from the tobacco companies and subsidiaries [press release]. Boston: Harvard School of Public Health; 2002. p. 1-2.
85. Shield M. Policies and positions of other organizations on the funding controversy. TRDRP Newsletter, Burning Issues 2001;4:2-4.
86. Cohen J. Accepting tobacco funding for research: an overview of the issues. TRDRP Newsletter Burning Issues 2003;6:7-10.